Here are some highlights from our coverage this week:
We compiled a list of the 15 most active VC investors in the past year, including their investment/exit counts and the sector in which each made the largest portion of their deals during the time period (excluding software). Check out the list here. For the underlying data on the firms included, click here.
Using our custom list upload tool, we uploaded every company backed by Y Combinator over the past four years to see which investors are most actively funding startups that run through the accelerator's program. Check out the five most active investors here. For the full list, click here to access the PitchBook Platform.
Bristol-Myers' agreement to acquire Flexus Biosciences will mark a massive (and quick) exit for investors, including Kleiner Perkins Caufield & Byers. Flexus' valuation skyrocketed from $18 million to its purchase price of $1.25 billion in only about 16 months. Read more about the deal here. To explore KPCB's investment and exit history, click here.
As always, feel free to browse through the PitchBook Blog for in-depth coverage of a broad range of topics surrounding venture capital, private equity and M&A: click here.